PRELUDE THERAPEUTICS INC

PRLD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 May 24, 2023
SC 13D/A May 24, 2023 AMENDMENT NO. 2
SC 13D/A May 24, 2023 SC 13D/A
4 May 24, 2023 FORM 4 SUBMISSION
424B5 May 19, 2023 424B5
8-K May 19, 2023 8-K
FWP May 18, 2023 FWP
424B5 May 17, 2023 424B5
8-K May 17, 2023 8-K
10-Q May 8, 2023 10-Q
8-K May 8, 2023 8-K
ARS Apr 28, 2023 ARS
DEFA14A Apr 28, 2023 DEFA14A
DEF 14A Apr 28, 2023 DEF 14A
PRE 14A Apr 18, 2023 PRE 14A
4 Apr 6, 2023 PRIMARY DOCUMENT
8-K Mar 15, 2023 8-K
424B5 Mar 15, 2023 424B5
S-8 Mar 15, 2023 S-8
10-K Mar 15, 2023 10-K
8-K Mar 15, 2023 8-K
4 Mar 2, 2023 PRIMARY DOCUMENT
3 Feb 22, 2023 PRIMARY DOCUMENT
8-K Feb 14, 2023 8-K
SC 13G Feb 13, 2023
← Newer Page 8 of 16 · 389 filings Older →